The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.8

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 20-24

Both Sexes
Site 1975-2012 2003-2012
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 24,504 34.3 0.8* 7,440 38.1 0.8*
1. Leukemias 1,583 2.2 0.9* 480 2.5 0.9*
2. Lymphomas 5,123 7.2 0.8* 1,483 7.6 -0.1
3. CNS, intracranial, intraspinal 1,624 2.3 0.7* 487 2.5 0.7*
4. Osseous & chondromatous neoplasms 653 0.9 1.2* 210 1.1 1.2*
5. Soft tissue sarcomas 1,498 2.1 0.9 374 1.9 -1.2*
6. Germ cell and trophoblastic neoplasms 3,809 5.3 0.8* 1,167 6.0 0.8*
7. Melanoma and skin carcinomas 3,081 4.3 1.1* 974 5.0 1.1*
8. Carcinomas (excluding skin) 6,733 9.4 0.4 2,145 11.0 1.5*
9. Miscellaneous specified neoplasms, NOS 250 0.3 1.4* 83 0.4 1.4*
10. Unspecified malignant neoplasms 150 0.2 0.1 37 0.2 0.1
Males
Site 1975-2012 2003-2012
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 12,042 33.2 0.5* 3,549 35.5 0.5*
1. Leukemias 910 2.5 0.6 262 2.6 0.6
2. Lymphomas 2,754 7.6 0.4* 794 7.9 0.4*
3. CNS, intracranial, intraspinal 905 2.5 0.1 235 2.3 0.1
4. Osseous & chondromatous neoplasms 380 1.0 0.8 121 1.2 0.8
5. Soft tissue sarcomas 890 2.5 0.5 218 2.2 -2.4*
6. Germ cell and trophoblastic neoplasms 3,407 9.4 0.8* 1,055 10.5 0.8*
7. Melanoma and skin carcinomas 1,056 2.9 0.2 301 3.0 0.2
8. Carcinomas (excluding skin) 1,588 4.4 1.1 520 5.2 5.5*
9. Miscellaneous specified neoplasms, NOS 95 0.3 - 29 0.3 -
10. Unspecified malignant neoplasms 57 0.2 - - - -
Females
Site 1975-2012 2003-2012
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 12,462 35.4 1.0* 3,891 40.9 1.0*
1. Leukemias 673 1.9 0.3 218 2.3 0.1
2. Lymphomas 2,369 6.7 1.1* 689 7.2 -0.3
3. CNS, intracranial, intraspinal 719 2.0 1.5* 252 2.6 1.5*
4. Osseous & chondromatous neoplasms 273 0.8 1.6* 89 0.9 1.6*
5. Soft tissue sarcomas 608 1.7 -0.7 156 1.6 -5.6
6. Germ cell and trophoblastic neoplasms 402 1.1 0.2 112 1.2 0.2
7. Melanoma and skin carcinomas 2,025 5.7 1.6* 673 7.1 1.6*
8. Carcinomas (excluding skin) 5,145 14.6 0.5 1,625 17.1 1.5*
9. Miscellaneous specified neoplasms, NOS 155 0.4 1.7* 54 0.6 1.7*
10. Unspecified malignant neoplasms 93 0.3 - 23 0.2 -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2012.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.